Orbimed Advisors LLC Terns Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
A detailed history of Orbimed Advisors LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 7,562,971 shares of TERN stock, worth $43.6 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
7,562,971
Previous 7,619,135
0.74%
Holding current value
$43.6 Million
Previous $51.9 Million
21.56%
% of portfolio
1.49%
Previous 1.25%
Shares
4 transactions
Others Institutions Holding TERN
# of Institutions
167Shares Held
78.3MCall Options Held
580KPut Options Held
454K-
Vivo Capital, LLC Palo Alto, CA6.9MShares$39.8 Million8.42% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.22MShares$35.9 Million4.41% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$32.2 Million1.71% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$23.8 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$21.2 Million0.01% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $217M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...